What is PROVENGE?
PROVENGE, the first FDA-approved autologous cellular immunotherapy, is a breakthrough treatment that uses a patient's own antigen-presenting cells to stimulate the body's immune system against prostate cancer.
Learn more about how PROVENGE is designed to work.
The information on this site will be updated as new information and resources become available. Watch the PROVENGE Journey video to learn more about how PROVENGE is made.
For information such as ordering, scheduling, tracking, and general coverage and reimbursement
questions, contact a Dendreon ON Call specialist at (877) 336-3736.
Please visit Dendreon.com to learn more
about our mission to target cancer and transform lives through the discovery, development, and
commercialization of novel therapeutics.